Overall, our findings suggest that repeated infusions of ketamine may produce a positive and longer-term effect on BMD, and leptin and OC may be the potential biomarkers of antidepressant response to ketamine in female and male patients with depression, respectively. Here, LEP is linked to depressive disorder.